NEW YORK (TheStreet) -- Hologic (HOLX) - Get Report shares are gaining 1.31% to $34.80 in Monday's pre-market trading session following the S&P Dow Jones Indices' announcement last week that the company will join the S&P 500 Index after the market close on Tuesday.
The Marlborough, MA-based company will replace Pepco Holdings (PEP) which is being acquired by Exelon Corp. (EXC).
Specifically, Hologic will be added to the S&P 500 GICS (Global Industry Classification Standard) Health Care Equipment Sub-Industry Index, the S&P Dow Jones Indices said on Thursday afternoon.
Hologic develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women in the U.S., Europe, the Asia-Pacific, and internationally.
Separately, TheStreet Ratings currently has a "Buy" rating on the stock with a letter grade of B.
The company's strengths can be seen in multiple areas, such as its impressive record of earnings per share growth, compelling growth in net income, revenue growth, good cash flow from operations and expanding profit margins. We feel its strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated.
Recently, TheStreet Ratings objectively rated this stock according to its "risk-adjusted" total return prospect over a 12-month investment horizon. Not based on the news in any given day, the rating may differ from Jim Cramer's view or that of this articles's author.
You can view the full analysis from the report here: HOLX